GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Vystar Corp (OTCPK:VYST) » Definitions » Research & Development

Vystar (Vystar) Research & Development : $0.00 Mil (TTM As of Sep. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Vystar Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Vystar's Research & Development for the three months ended in Sep. 2023 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00 Mil.


Vystar Research & Development Historical Data

The historical data trend for Vystar's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vystar Research & Development Chart

Vystar Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Vystar Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Vystar Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vystar  (OTCPK:VYST) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Vystar Research & Development Related Terms

Thank you for viewing the detailed overview of Vystar's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Vystar (Vystar) Business Description

Traded in Other Exchanges
N/A
Address
725 Southbridge Street, Worcester, MA, USA, 01610
Vystar Corp is engaged in the rubber and plastic products market. It develops technology to produce Vytex Natural Rubber Latex which reduces antigenic protein and non-rubbers in natural rubber latex to undetectable levels. The company's products and services include Natural Rubber Latex, and clinical sleep diagnostics and durable medical equipment. The company derives revenue from sales of or license fees of Vytex NRL raw material to manufacturers and distributors of rubber and rubber end products.
Executives
Byron Lee Novosad other: Board Member 14019 SW FREEWAY, # 301 PMB 181, SUGAR LAND TX 77478
Bryan Lawrence Stone director C/O VYSTAR CORPORATION, 101 AYLESBURY RD., WORCESTER MA 01609
Keith D. Osborn 10 percent owner 5671 PEACHTREE-DUNWOODY RD., ATLANTA GA 30342
Paul R. Oristaglio director 955 COUNTY ROAD, BARRINGTON RI 02806
Steven Rotman director, officer: Chief Executive Officer C/O VYSTAR CORPORATION, 101 AYLESBURY RD., WORCESTER MA 01609
Joseph Carmen Allegra director C/O VYSTAR CORPORATION, 101 AYLESBURY RD., WORCESTER MA 01609
William R. Doyle director, officer: Chairman, President & CEO VYSTAR CORPORATION, 3235 SATELLITE BLVD, BUILDING 400, SUITE 290, DULUTH GA 30096
Joseph Allegra director VYSTAR CORPORATION, 3235 SATELLITE BLVD., BUILDING 400, SUITE 290, DULUTH GA 30096
Jason M. Meggs director C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560
Ranjit K. Matthan director C/O VYSTAR CORPORATION, 2484 BRIARCLIFF RD NE, SUITE 159, ATLANTA GA 30329
Mangum Michelle (mitsy) Y. director VYSTAR CORPORATION, 3235 SATELLITE BLVD, BUILDING 400, SUITE 290, DULUTH GA 30096
Michael X Ianacone director C/O VYSTAR CORPORATION, 2484 BRIARCLIFF RD NE, SUITE 159, ATLANTA GA 30329
Thomas L Mills director C/O WINSTON & STRAWN,, 1400 L. STREET, N.W, WASHINGTON DC 20005
Paul A. Yeoham director C/O VYSTAR CORP., 3235 SATELLITE BLVD., BUILDING 400, SUITE 290, DULUTH GA 30096
Dale Thomas Marsh director C/O VYSTAR CORPORATION, 3235 SATELLITE BLVD., BLDG. 400, STE 290, DULUTH GA 30096